State Street Corporation 13D and 13G filings for BioCryst Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-17 11:52 am Sale | 2024-09-30 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | STATE STREET CORP STT | 8,849,588 4.300% | -3,927,415 (-30.74%) | Filing |
| 2024-01-24 1:06 pm Purchase | 2023-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | STATE STREET CORP STT | 12,777,003 6.240% | 1,650,142 (+14.83%) | Filing |
| 2023-02-06 09:33 am Purchase | 2022-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | STATE STREET CORP STT | 11,126,861 5.970% | 2,877,832 (+34.89%) | Filing |
| 2022-02-09 11:33 am Purchase | 2021-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | STATE STREET CORP STT | 8,249,029 4.580% | 940,213 (+12.86%) | Filing |
| 2021-04-12 09:36 am Sale | 2021-03-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | STATE STREET CORP STT | 7,308,816 4.130% | -3,748,163 (-33.90%) | Filing |
| 2021-02-05 11:42 am Sale | 2020-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | STATE STREET CORP STT | 11,056,979 6.260% | -6,896,891 (-38.41%) | Filing |
| 2020-12-10 07:14 am Purchase | 2020-11-30 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | STATE STREET CORP STT | 17,953,870 10.170% | 17,953,870 (New Position) | Filing |